Medicskin Holdings (SEHK:8307) - Aandelenkoers, Nieuws & Analyse

8307 Overzicht aandelen

Medicskin Holdings Limited, een investeringsholding, biedt medische huidverzorgingsdiensten aan in Hong Kong. Meer informatie

8307 fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Verhandeld tegen 86.4% onder onze schatting van de reële waarde

Risicoanalyse

De winst is de afgelopen 5 jaar met 14.7% per jaar gedaald

Heeft geen betekenisvolle marktkapitalisatie ( HK$75M )

Volatiele aandelenkoers in de afgelopen 3 maanden

Medicskin Holdings Limited Concurrenten

Republic Healthcare

SEHK:8357

HK$49.3m

Mediwelcome Healthcare Management & Technology

SEHK:2159

HK$74.0m

Meihao Medical Group

SEHK:1947

HK$195.1m

Clarity Medical Group Holding

SEHK:1406

HK$211.6m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Medicskin Holdings
Historische aandelenkoersen
Huidige aandelenkoers	HK$0.19
52 Week Hoogtepunt	HK$0.22
52 Week Laag	HK$0.092
Bèta	0.28
11 maand verandering	-4.06%
3 maanden verandering	26.00%
1 Jaar Verandering	-3.57%
33 jaar verandering	9.25%
5 jaar verandering	-10.00%
Verandering sinds IPO	-93.94%

Recent nieuws en updates

Recent updates

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

Sep 16

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Jul 18

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Jun 11

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Feb 25

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Sep 15

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Feb 11

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

Dec 16

Rendement voor aandeelhouders

	8307	HK Healthcare	HK Markt
7D	-0.5%	-1.5%	-0.6%
1Y	-3.6%	-27.6%	9.6%

Rendement versus industrie: 8307 overtrof de Hong Kong Healthcare industrie, die het afgelopen jaar een rendement -27.6 % opleverde.

Rendement versus markt: 8307 presteerde slechter dan Hong Kong Market, dat het afgelopen jaar een rendement van 9.6 % opleverde.

Prijsvolatiliteit

Is 8307's price volatile compared to industry and market?
8307 volatility
8307 Average Weekly Movement	16.0%
Healthcare Industry Average Movement	8.0%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.2%
10% least volatile stocks in HK Market	4.3%

Stabiele aandelenkoers: De aandelenkoers van 8307 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 16% ) van 8307 is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Hong Kong.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2000	36	Kwok Leung Kong	www.medicskin.com

Medicskin Holdings Limited, een beleggingsholding, biedt medische huidverzorgingsdiensten aan in Hong Kong. Het bedrijf beheert Medicskin-centra, die verschillende medische huidverzorgingsdiensten aanbieden voor de behandeling van huidziekten en -problemen, zoals acne, pigmentatie, rosacea, dermatitis, eczeem en wratten, evenals verbetering van het uiterlijk door onder andere huidverjonging, gezichtssculptuur en lichaamscontourbehandelingen; en behandeling van acnelittekens en vergrote poriën, verwijdering van ongewenste naevi en ontharing. Het bedrijf levert medische consultancydiensten.

Medicskin Holdings Limited Samenvatting

Hoe verhouden de winst en inkomsten van Medicskin Holdings zich tot de beurswaarde?
8307 fundamentele statistieken
Marktkapitalisatie	HK$74.98m
Inkomsten(TTM)	-HK$2.96m
Inkomsten(TTM)	HK$48.36m

1.6x

P/S-verhouding

-25.3x

Koers/Winstverhouding

Is 8307 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
8307 resultatenrekening (TTM)
Inkomsten	HK$48.36m
Kosten van inkomsten	HK$33.20m
Brutowinst	HK$15.16m
Overige uitgaven	HK$18.12m
Inkomsten	-HK$2.96m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.0075
Brutomarge	31.35%
Nettowinstmarge	-6.12%
Schuld/Eigen Vermogen Verhouding	162.7%

Hoe presteerde 8307 op de lange termijn?

Bekijk historische prestaties en vergelijking

8307 Overzicht aandelen

Beloningen

Risicoanalyse

Medicskin Holdings Limited Concurrenten

SEHK:8357

HK$49.3m

SEHK:2159

HK$74.0m

SEHK:1947

HK$195.1m

SEHK:1406

HK$211.6m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

New major risk - Revenue and earnings growth

Medicskin Holdings Limited to Report First Half, 2025 Results on Nov 21, 2024

New major risk - Market cap size

Medicskin Holdings Limited, Annual General Meeting, Sep 06, 2024

Full year 2024 earnings released: HK$0.008 loss per share (vs HK$0.008 loss in FY 2023)

Now 34% overvalued after recent price rise

Recent updates

New major risk - Revenue and earnings growth

Medicskin Holdings Limited to Report First Half, 2025 Results on Nov 21, 2024

New major risk - Market cap size

Medicskin Holdings Limited, Annual General Meeting, Sep 06, 2024

Full year 2024 earnings released: HK$0.008 loss per share (vs HK$0.008 loss in FY 2023)

Now 34% overvalued after recent price rise

New minor risk - Financial data availability

Medicskin Holdings Limited to Report Fiscal Year 2024 Results on Jun 19, 2024

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Now 23% undervalued after recent price drop

Second quarter 2024 earnings released: HK$0.004 loss per share (vs HK$0.006 loss in 2Q 2023)

New major risk - Market cap size

Medicskin Holdings Limited to Report Q2, 2024 Results on Nov 13, 2023

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Medicskin Holdings Limited Announces Appointment of Lui Sze On as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from September 6, 2023

New minor risk - Financial position

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

Medicskin Holdings Limited to Report Q1, 2024 Results on Aug 14, 2023

Medicskin Holdings Limited, Annual General Meeting, Sep 01, 2023

New minor risk - Share price stability

Full year 2023 earnings released: HK$0.007 loss per share (vs HK$0.01 profit in FY 2022)

Medicskin Holdings Limited Announces Resignation of Fu Frank Tsun Yin as Independent Non-Executive Director and A Member of the Audit Committee, Remuneration Committee and Nomination Committee

Medicskin Holdings Limited to Report Fiscal Year 2023 Results on Jun 21, 2023

Medicskin Holdings Limited Appoints Fu Frank Tsun Yin as an Independent Non-Executive Director and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 February 2023

Third quarter 2023 earnings released: EPS: HK$0 (vs HK$0.004 in 3Q 2022)

Medicskin Holdings Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: HK$0.006 loss per share (vs HK$0.001 profit in 2Q 2022)

Medicskin Holdings Limited Announces Resignation of Lee Ka Lun as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee

Less than half of directors are independent

Medicskin Holdings Limited Provides Unaudited Consolidated Earnings Guidance for Six Months Ended 30 September 2022

Medicskin Holdings Limited to Report First Half, 2023 Results on Nov 14, 2022

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

First quarter 2023 earnings released: HK$0.002 loss per share (vs HK$0.004 profit in 1Q 2022)

Medicskin Holdings Limited Provides Consolidated Earnings Guidance for the Three Months Ended June 30, 2022

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Full year 2022 earnings released

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Medicskin Holdings Limited to Report Fiscal Year 2022 Results on Jun 20, 2022

Less than half of directors are independent

Now 20% undervalued

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS HK$0.001 (vs HK$0.002 in 2Q 2021)

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

First quarter 2022 earnings released: EPS HK$0.004 (vs HK$0.002 in 1Q 2021)

Inaugural dividend of HK$0.025 per share

Full year 2021 earnings released: EPS HK$0.002 (vs HK$0.007 loss in FY 2020)

Medicskin Holdings Limited Announces Special Dividend for the Year Ended 31 March 2021, Payable on or around 26 July 2021

New 90-day high: HK$0.29

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Third quarter 2021 earnings released: EPS HK$0.004 (vs HK$0.001 loss in 3Q 2020)

New 90-day high: HK$0.28

Medicskin Holdings Limited to Report Nine Months, 2021 Results on Feb 10, 2021

New 90-day high: HK$0.22

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary